Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
Marta Valenciano,Esther Kissling,Jean-Marie Cohen,Beatrix Oroszi,Anne-Sophie Barret,Caterina Rizzo,Baltazar Nunes,Daniela Pitigoi,Amparro Larrauri Cámara,Anne Mosnier,Judith Krisztina Horváth,Joan O'Donnell,Antonino Bella,Raquel Guiomar,Emilia Lupulescu,Camelia Savulescu,Bruno Christian Ciancio,Piotr Kramarz,Alain Moren +18 more
Reads0
Chats0
TLDR
Results from a European multicentre case-control study reported by Marta Valenciano and colleagues suggest good protection by the pandemic monovalent H 1N1 vaccine against pH1N1 and no effect of the 2009–2010 seasonal influenza vaccine on H1n1.Abstract:
Background
A multicentre case-control study based on sentinel practitioner surveillance networks from seven European countries was undertaken to estimate the effectiveness of 2009–2010 pandemic and seasonal influenza vaccines against medically attended influenza-like illness (ILI) laboratory-confirmed as pandemic influenza A (H1N1) (pH1N1).
Methods and Findings
Sentinel practitioners swabbed ILI patients using systematic sampling. We included in the study patients meeting the European ILI case definition with onset of symptoms >14 days after the start of national pandemic vaccination campaigns. We compared pH1N1 cases to influenza laboratory-negative controls. A valid vaccination corresponded to >14 days between receiving a dose of vaccine and symptom onset. We estimated pooled vaccine effectiveness (VE) as 1 minus the odds ratio with the study site as a fixed effect. Using logistic regression, we adjusted VE for potential confounding factors (age group, sex, month of onset, chronic diseases and related hospitalizations, smoking history, seasonal influenza vaccinations, practitioner visits in previous year). We conducted a complete case analysis excluding individuals with missing values and a multiple multivariate imputation to estimate missing values. The multivariate imputation (n = 2902) adjusted pandemic VE (PIVE) estimates were 71.9% (95% confidence interval [CI] 45.6–85.5) overall; 78.4% (95% CI 54.4–89.8) in patients <65 years; and 72.9% (95% CI 39.8–87.8) in individuals without chronic disease. The complete case (n = 1,502) adjusted PIVE were 66.0% (95% CI 23.9–84.8), 71.3% (95% CI 29.1–88.4), and 70.2% (95% CI 19.4–89.0), respectively. The adjusted PIVE was 66.0% (95% CI −69.9 to 93.2) if vaccinated 8–14 days before ILI onset. The adjusted 2009–2010 seasonal influenza VE was 9.9% (95% CI −65.2 to 50.9).
Conclusions
Our results suggest good protection of the pandemic monovalent vaccine against medically attended pH1N1 and no effect of the 2009–2010 seasonal influenza vaccine. However, the late availability of the pandemic vaccine and subsequent limited coverage with this vaccine hampered our ability to study vaccine benefits during the outbreak period. Future studies should include estimation of the effectiveness of the new trivalent vaccine in the upcoming 2010–2011 season, when vaccination will occur before the influenza season starts.
Please see later in the article for the Editors' Summaryread more
Citations
More filters
Journal ArticleDOI
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
TL;DR: Influenza vaccines can provide moderate protection against virologically confirmed influenza, but such protection is greatly reduced or absent in some seasons.
On the european union
TL;DR: In this article, the authors examined the patterns and effects of departmental oversight across 28 ministries in Estonia, Hungary, Poland and Slovenia in relation to transposition planning, legal review and monitoring of deadlines.
Journal ArticleDOI
Vaccines for preventing influenza in healthy children
Sue Erica Smith,Vittorio Demicheli,C Di Pietrantonj,Anthony Harnden,Tom Jefferson,Nicholas J Matheson,A Rivetti +6 more
TL;DR: In this paper, the authors found that in children aged from two years, nasal spray vaccines made from weakened influenza viruses were better at preventing illness caused by the influenza virus than injected vaccine made from the killed virus.
Journal ArticleDOI
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Edward A. Belongia,Melissa Simpson,Jennifer P. King,Maria E. Sundaram,Nicholas S. Kelley,Michael T. Osterholm,Huong Q. McLean +6 more
TL;DR: A systematic review and meta-analysis of Influenza vaccine effectiveness (VE) found vaccines provided substantial protection against H1N1pdm09, H1n1 (pre-2009), and type B, and reduced Protection against H3N2.
Journal ArticleDOI
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
TL;DR: Nonclinical and clinical data illustrate the ability of AS03 to induce superior adaptive responses against the vaccine antigen, principally in terms of antibody levels and immune memory, and support the concept of Adjuvant Systems as a plausible approach to develop new effective vaccines.
References
More filters
Journal ArticleDOI
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.
Jonathan A C Sterne,Ian R. White,John B. Carlin,Michael Spratt,Patrick Royston,Michael G. Kenward,Angela M. Wood,James R. Carpenter +7 more
TL;DR: The appropriate use and reporting of the multiple imputation approach to dealing with missing data is described by Jonathan Sterne and colleagues.
Journal ArticleDOI
Traditional reviews, meta-analyses and pooled analyses in epidemiology.
Maria Blettner,Willi Sauerbrei,Brigitte Schlehofer,Thomas Scheuchenpflug,Christine M. Friedenreich +4 more
TL;DR: For a full assessment of risk factors with a high prevalence in the general population, pooling of data will become increasingly important and future research needs to focus on the deficiencies of review methods.
Journal ArticleDOI
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.
Tristan W Clark,Manish Pareek,Katja Hoschler,Helen Dillon,Karl G. Nicholson,Nicola Groth,Iain Stephenson +6 more
TL;DR: Monovalent 2009 influenza A (H1N1) MF59-adjuvanted vaccine generates antibody responses likely to be associated with protection after a single dose is administered.
Journal ArticleDOI
Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season
Edward A. Belongia,Burney A. Kieke,James G. Donahue,Robert T. Greenlee,Amanda Balish,Angie Foust,Stephen Lindstrom,David K. Shay +7 more
TL;DR: Investigation of the effectiveness of inactivated influenza vaccines for the prevention of laboratory-confirmed, medically attended influenza during 3 seasons with variable antigenic match between vaccine and patient strains found Influenza VE varied substantially across 3 seasons and was highest when antigenicMatch was optimal.
Journal ArticleDOI
Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada
Danuta M. Skowronski,Gaston De Serres,Natasha S. Crowcroft,Naveed Z. Janjua,Nicole Boulianne,Travis S. Hottes,Laura C. Rosella,James A. Dickinson,Rodica Gilca,Pam Sethi,Najwa Ouhoummane,Donald J. Willison,Isabelle Rouleau,Martin Petric,Kevin Fonseca,Steven J. Drews,Anuradha Rebbapragada,Hugues Charest,Marie-Ève Hamelin,Guy Boivin,Jennifer L. Gardy,Yan Li,Trijntje L. Kwindt,David M. Patrick,Robert C. Brunham +24 more
TL;DR: Prior receipt of 2008-09 TIV was associated with increased risk of medically attended pH1N1 illness during the spring-summer 2009 in Canada and possible biological mechanisms and immunoepidemiologic implications are considered.
Related Papers (5)
I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe
Esther Kissling,Marta Valenciano,J.-M. Cohen,Beatrix Oroszi,Anne Sophie Barret,Caterina Rizzo,Paweł Stefanoff,Baltazar Nunes,Daniela Pitigoi,Amparo Larrauri,Isabelle Daviaud,Judit Krisztina Horváth,Joan O'Donnell,Thomas Seyler,Iwona Paradowska-Stankiewicz,Pedro Pechirra,Alina Elena Ivanciuc,Silvia Jiménez-Jorge,Camelia Savulescu,Bruno Christian Ciancio,Alain Moren +20 more